Key statistics
On Thursday, Pharming Group NV (PHGN:BER) closed at 0.711, 9.72% above its 52-week low of 0.648, set on Sep 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.711 |
---|---|
High | 0.711 |
Low | 0.711 |
Bid | 0.7085 |
Offer | 0.7155 |
Previous close | 0.684 |
Average volume | 3.65k |
---|---|
Shares outstanding | 678.35m |
Free float | 662.48m |
P/E (TTM) | -- |
Market cap | 471.45m EUR |
EPS (TTM) | -0.0189 EUR |
Data delayed at least 15 minutes, as of Sep 26 2024 07:02 BST.
More ▼
Announcements
- Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
- Pharming Group to participate in September investor conferences
- Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
- Pharming Group reports second quarter and first half 2024 financial results and provides business update
- Pharming Group to report second quarter and first half 2024 financial results on August 1
- Pharming Group to participate in June investor conferences
- Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
- Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
- Pharming Group to participate in May investor conference
- Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
More ▼